TIA1 regulates the generation and response to toxic tau oligomers

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1432-0533

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: TIA1 regulates the generation and response to toxic tau oligomers ; day:21 ; month:11 ; year:2018 ; pages:1-19
Acta neuropathologica ; (21.11.2018), 1-19

Creator: Jiang, Lulu
Ash, Peter E. A.
Maziuk, Brandon F.
Ballance, Heather I.
Boudeau, Samantha
Abdullatif, Ali Al
Orlando, Marcello
Petrucelli, Leonard
Ikezu, Tsuneya
Wolozin, Benjamin

Contributor: SpringerLink (Online service)

DOI: 10.1007/s00401-018-1937-5

URN: urn:nbn:de:101:1-2019010421512079938987

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:03 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Jiang, Lulu
Ash, Peter E. A.
Maziuk, Brandon F.
Ballance, Heather I.
Boudeau, Samantha
Abdullatif, Ali Al
Orlando, Marcello
Petrucelli, Leonard
Ikezu, Tsuneya
Wolozin, Benjamin
SpringerLink (Online service)

Other Objects (12)

Amyloid-β oligomers increase the binding and internalization of tau oligomers in human synapses

Near Infrared Light Treatment Reduces Synaptic Levels of Toxic Tau Oligomers in Two Transgenic Mouse Models of Human Tauopathies

Backbone NMR assignments of HypF-N under conditions generating toxic and non-toxic oligomers

Microglia display modest phagocytic capacity for extracellular tau oligomers

Tau oligomers accumulation sensitizes prostate cancer cells to docetaxel treatment

Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation

Baicalein inhibits heparin-induced Tau aggregation by initializing non-toxic Tau oligomer formation

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

QIAD assay for quantitating a compound's efficacy in elimination of toxic Aβ oligomers

Correction to: Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation

Phagocytosis of full-length Tau oligomers by Actin-remodeling of activated microglia

Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy

Amyloid-β oligomers increase the binding and internalization of tau oligomers in human synapses

Near Infrared Light Treatment Reduces Synaptic Levels of Toxic Tau Oligomers in Two Transgenic Mouse Models of Human Tauopathies

Backbone NMR assignments of HypF-N under conditions generating toxic and non-toxic oligomers

Microglia display modest phagocytic capacity for extracellular tau oligomers

Tau oligomers accumulation sensitizes prostate cancer cells to docetaxel treatment

Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation

Baicalein inhibits heparin-induced Tau aggregation by initializing non-toxic Tau oligomer formation

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

QIAD assay for quantitating a compound's efficacy in elimination of toxic Aβ oligomers

Correction to: Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation

Phagocytosis of full-length Tau oligomers by Actin-remodeling of activated microglia

Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy

Amyloid-β oligomers increase the binding and internalization of tau oligomers in human synapses

Near Infrared Light Treatment Reduces Synaptic Levels of Toxic Tau Oligomers in Two Transgenic Mouse Models of Human Tauopathies

Backbone NMR assignments of HypF-N under conditions generating toxic and non-toxic oligomers

Microglia display modest phagocytic capacity for extracellular tau oligomers

Tau oligomers accumulation sensitizes prostate cancer cells to docetaxel treatment

Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation

Baicalein inhibits heparin-induced Tau aggregation by initializing non-toxic Tau oligomer formation

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

QIAD assay for quantitating a compound's efficacy in elimination of toxic Aβ oligomers

Correction to: Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation

Phagocytosis of full-length Tau oligomers by Actin-remodeling of activated microglia

Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

TIA1 regulates the generation and response to toxic tau oligomers

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Amyloid-β oligomers increase the binding and internalization of tau oligomers in human synapses

Near Infrared Light Treatment Reduces Synaptic Levels of Toxic Tau Oligomers in Two Transgenic Mouse Models of Human Tauopathies

Backbone NMR assignments of HypF-N under conditions generating toxic and non-toxic oligomers

Microglia display modest phagocytic capacity for extracellular tau oligomers

Tau oligomers accumulation sensitizes prostate cancer cells to docetaxel treatment

Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation

Baicalein inhibits heparin-induced Tau aggregation by initializing non-toxic Tau oligomer formation

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

QIAD assay for quantitating a compound's efficacy in elimination of toxic Aβ oligomers

Correction to: Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation

Phagocytosis of full-length Tau oligomers by Actin-remodeling of activated microglia

Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy

Amyloid-β oligomers increase the binding and internalization of tau oligomers in human synapses

Near Infrared Light Treatment Reduces Synaptic Levels of Toxic Tau Oligomers in Two Transgenic Mouse Models of Human Tauopathies

Backbone NMR assignments of HypF-N under conditions generating toxic and non-toxic oligomers

Microglia display modest phagocytic capacity for extracellular tau oligomers

Tau oligomers accumulation sensitizes prostate cancer cells to docetaxel treatment

Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation

Baicalein inhibits heparin-induced Tau aggregation by initializing non-toxic Tau oligomer formation

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

QIAD assay for quantitating a compound's efficacy in elimination of toxic Aβ oligomers

Correction to: Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation

Phagocytosis of full-length Tau oligomers by Actin-remodeling of activated microglia

Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy

Amyloid-β oligomers increase the binding and internalization of tau oligomers in human synapses

Near Infrared Light Treatment Reduces Synaptic Levels of Toxic Tau Oligomers in Two Transgenic Mouse Models of Human Tauopathies

Backbone NMR assignments of HypF-N under conditions generating toxic and non-toxic oligomers

Microglia display modest phagocytic capacity for extracellular tau oligomers

Tau oligomers accumulation sensitizes prostate cancer cells to docetaxel treatment

Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation

Baicalein inhibits heparin-induced Tau aggregation by initializing non-toxic Tau oligomer formation

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

QIAD assay for quantitating a compound's efficacy in elimination of toxic Aβ oligomers

Correction to: Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation

Phagocytosis of full-length Tau oligomers by Actin-remodeling of activated microglia

Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy

Related objects

Reset password